Results 21 to 30 of about 56,955 (209)

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group [PDF]

open access: yes, 2012
INTRODUCTION: Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known.
Smith, Vanessa   +62 more
core   +1 more source

Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis

open access: yesArthritis Research & Therapy, 2018
Background A pivotal role for adipose tissue homeostasis in systemic sclerosis (SSc) skin fibrosis is increasingly recognized. The nuclear receptor PPAR-γ is the master regulator of adipogenesis.
Benjamin Korman   +5 more
doaj   +1 more source

From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution

open access: yesDermatology Research and Practice, 2018
Background. Systemic sclerosis (SSc) and localized scleroderma (LoS) are two different diseases that may share some features. We evaluated the relationship between SSc and LoS in our case series of SSc patients. Methods.
Giuggioli Dilia   +5 more
doaj   +1 more source

Localized scleroderma – current treatment options [PDF]

open access: yes, 2017
Localized scleroderma (morphea) is a connective tissue disease that affects the skin, subcutaneous tissue and underlying tissues including the fasciae, muscles and bones. The treatment of localized scleroderma depends on the clinical form of the disease,
Małgorzata Michalska-Jakubus   +2 more
core   +1 more source

Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts [PDF]

open access: yes, 2009
Background: Fibrosis, the excessive deposition of scar tissue by fibroblasts, is one of the largest groups of diseases for which there is no therapy. Fibroblasts from lesional areas of scleroderma patients possess elevated abilities to contract matrix ...
Christopher P Denton   +26 more
core   +1 more source

Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with negative physical and psychological implications. Sources of emotional distress and the impact they have on the lives of people with scleroderma are not ...
Stephanie T Gumuchian   +13 more
doaj   +1 more source

Fibrosing arthropathy in juvenile scleroderma

open access: yesСовременная ревматология, 2021
The group of scleroderma diseases includes a number of clinical entities, the main symptom of which is skin tightening. Scleroderma is a prominent example of these diseases, characterized by excessive synthesis and deposition of collagen in organs and ...
D. A. Dibrov   +2 more
doaj   +1 more source

Treatment Algorithms for Systemic Sclerosis According to Experts [PDF]

open access: yes, 2018
OBJECTIVE: There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.
Walker KM   +4 more
core   +3 more sources

Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell carcinoma [PDF]

open access: yes, 2021
Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell ...
Ruffilli, Francesca   +5 more
core   +1 more source

Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study

open access: yesArthritis Research & Therapy, 2017
Background Prokinetics are used to treat enteric dismotility symptoms in systemic sclerosis (SSc) patients, but they often lack adequate efficacy. The most effective prokinetics belonging to the serotonin (5-HT4) receptor agonists class were withdrawn ...
Barbara Vigone   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy